How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Want to read, speak, or write in a new language but aren't sure where to start? These are the top language learning apps we've tested, no matter your budget, goals, or prior experience. I'm an expert ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Matthew Guay After a new round of testing, we found that the best app depends ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

Languages often co-express related meanings, either reusing words or combining parts of words. It is poorly understood when each strategy is favoured. Across 1,982 languages, Brochhagen et al. find ...

Artificial intelligence is rewriting the world and simultaneously inventing a whole new language to describe how it’s doing it. Sit in on any product meeting, pitch, or panel these days, and you’ll ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

C | Complete Citigroup Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.